HK ENT INTL (08291) will issue 160 million rights shares.

HK ENT INTL (08291) announced that, in relation to the rights issue on a "1 for 3" basis, as at 4:00 p.m. on October 12, 2026 (being the final deadline for the placing agent to place the unsubscribed rights shares), 72,879,900 unsubscribed rights shares were successfully placed under the placing to not fewer than 6 placees at a price of HK$0.20 per share (equal to the subscription price). Accordingly, there were no net proceeds distributable to non-acting shareholders. All conditions relating to the rights issue and the placing as set out in the rights issue prospectus have been fulfilled, and the rights issue and the placing became unconditional at 4:00 p.m. on October 12, 2026. Based on the acceptance results of the rights issue and the placing results, the rights shares to be allotted and issued will be 160 million rights shares, representing 100% of the total number of rights shares available for subscription under the rights issue. The gross proceeds from the rights issue are approximately HK$32 million. The net proceeds are approximately HK$31.2 million. The Company intends to apply the net proceeds from the rights issue as follows: (i) approximately HK$10 million for repayment of the Group's bonds payable, which mature on November 30, 2026; (ii) approximately HK$15 million for repayment of borrowings, which mature on November 30, 2026; and (iii) approximately HK$6.2 million as general working capital of the Group (including but not limited to payment of lease expenses, remuneration, professional fees and settlement of trade payables).